Neuroprotective Activity of Some Marine Fungal Metabolites in the 6-Hydroxydopamin- and Paraquat-Induced Parkinson's Disease Models
A new melatonin analogue 6-hydroxy-N-acetyl-β-oxotryptamine (1) was isolated from the marine-derived fungus Penicillium sp. KMM 4672. It is the second case of melatonin-related compounds isolation from microfilamentous fungi. The neuroprotective activities of this metabolite, as well as 3-methylorsellinic acid (2) and 8-methoxy-3,5-dimethylisochroman-6-ol (3) from Penicillium sp. KMM 4672, candidusin A (4) and 4″-dehydroxycandidusin A (5) from Aspergillus sp. KMM 4676, and diketopiperazine mactanamide (6) from Aspergillus flocculosus, were investigated in the 6-hydroxydopamine (6-OHDA)- and paraquat (PQ)-induced Parkinson’s disease (PD) cell models. All of them protected Neuro2a cells against the damaging influence of 6-OHDA to varying degrees. This effect may be realized via a reactive oxygen species (ROS) scavenging pathway. The new melatonin analogue more effectively protected Neuro2A cells against the 6-OHDA-induced neuronal death, in comparison with melatonin, as well as against the PQ-induced neurotoxicity. Dehydroxylation at C-3″ and C-4″ significantly increased free radical scavenging and neuroprotective activity of candidusin-related p-terphenyl polyketides in both the 6-OHDA- and PQ-induced PD models.
Top-30
Journals
|
1
2
3
4
5
6
|
|
|
International Journal of Molecular Sciences
6 publications, 16.22%
|
|
|
Marine Drugs
5 publications, 13.51%
|
|
|
Molecules
3 publications, 8.11%
|
|
|
Marine Life Science & Technology
2 publications, 5.41%
|
|
|
RSC Advances
2 publications, 5.41%
|
|
|
Biomedicines
1 publication, 2.7%
|
|
|
Journal of Fungi
1 publication, 2.7%
|
|
|
Phytochemistry
1 publication, 2.7%
|
|
|
PLoS ONE
1 publication, 2.7%
|
|
|
Pharmacological Research
1 publication, 2.7%
|
|
|
Chinese Journal of Chemistry
1 publication, 2.7%
|
|
|
Brazilian Journal of Microbiology
1 publication, 2.7%
|
|
|
Natural Product Reports
1 publication, 2.7%
|
|
|
CNS and Neurological Disorders - Drug Targets
1 publication, 2.7%
|
|
|
Oxygen
1 publication, 2.7%
|
|
|
Metabolites
1 publication, 2.7%
|
|
|
Neurodegenerative disease management
1 publication, 2.7%
|
|
|
Vietnam Journal of Marine Science and Technology
1 publication, 2.7%
|
|
|
Medical Advancements in Aging and Regenerative Technologies
1 publication, 2.7%
|
|
|
Mycobiology
1 publication, 2.7%
|
|
|
Archives of Microbiology
1 publication, 2.7%
|
|
|
1
2
3
4
5
6
|
Publishers
|
2
4
6
8
10
12
14
16
18
|
|
|
MDPI
18 publications, 48.65%
|
|
|
Springer Nature
4 publications, 10.81%
|
|
|
Elsevier
3 publications, 8.11%
|
|
|
Royal Society of Chemistry (RSC)
3 publications, 8.11%
|
|
|
Taylor & Francis
2 publications, 5.41%
|
|
|
Public Library of Science (PLoS)
1 publication, 2.7%
|
|
|
Wiley
1 publication, 2.7%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 2.7%
|
|
|
Publishing House for Science and Technology, Vietnam Academy of Science and Technology (Publications)
1 publication, 2.7%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 2.7%
|
|
|
IGI Global
1 publication, 2.7%
|
|
|
2
4
6
8
10
12
14
16
18
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.